Share Price and Basic Stock Data
Last Updated: December 18, 2025, 11:47 pm
| PEG Ratio | 0.18 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
HCP Plastene Bulkpack Ltd operates in the packaging and containers sector, a vital industry driven by rising consumer demand and innovative packaging solutions. For the fiscal year ending March 2025, the company reported sales of ₹463 Cr, a significant increase from ₹351 Cr in the previous fiscal year. This upward trajectory reflects the company’s ability to navigate market challenges and seize growth opportunities. However, looking at the quarterly sales figures, there was a dip in revenue from ₹111.04 Cr in June 2022 to ₹59.37 Cr in June 2023, followed by a recovery to ₹78.87 Cr in September 2023. This volatility raises questions about seasonality or operational challenges, necessitating close monitoring of future quarterly performances. The trailing twelve months (TTM) sales stood at ₹484 Cr, indicating a strong recovery trend, but investors should be cautious about sustainability in light of fluctuations in quarterly earnings.
Profitability and Efficiency Metrics
When examining profitability, HCP Plastene’s operating profit margin (OPM) of 7.28% for the fiscal year 2025 appears commendable, especially when compared to the previous year’s 6%. However, the company has experienced significant fluctuations in OPM over recent quarters, with a low of 2.32% in June 2023. This suggests potential issues with cost management or pricing power, especially given that expenses have not consistently aligned with sales growth. The net profit for FY 2025 was ₹13 Cr, a rebound from a loss of ₹2 Cr in FY 2022, showcasing a notable recovery but still raising concerns regarding the consistency of profitability. Efficiency metrics, such as return on equity (ROE) at 17.7% and return on capital employed (ROCE) at 13.2%, indicate that the company is leveraging its equity and capital effectively, yet the cash conversion cycle of 133 days is on the higher side, suggesting potential liquidity challenges that could impact operational flexibility.
Balance Sheet Strength and Financial Ratios
The balance sheet of HCP Plastene reflects a mixed picture. With total borrowings reported at ₹201 Cr against reserves of ₹57 Cr, the company is heavily leveraged, which is evident in its total debt-to-equity ratio of 3.19x. While this level of debt might be manageable in a growth phase, it poses risks, particularly in a rising interest rate environment. The interest coverage ratio (ICR) stands at 2.73x, indicating that the company generates sufficient operating income to cover its interest obligations, albeit with limited buffer. The book value per share has increased to ₹55.81, up from ₹46.39 the previous year, suggesting that the company is enhancing shareholder value despite its debt levels. Investors should consider the implications of high leverage, particularly in terms of financial flexibility and risk exposure to market fluctuations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of HCP Plastene reveals a strong promoter commitment, with promoters holding 75% of the equity as of March 2025. This level of ownership can be a positive signal for retail investors, as it indicates alignment of interests between management and shareholders. Institutional interest has been modest, with foreign institutional investors (FIIs) holding 4.50% of the stake, while domestic institutional investors (DIIs) maintain a steady 4.80%. Interestingly, public shareholding has seen fluctuations, rising to 20.13% in March 2025 from 6.04% in December 2022. This increase could indicate growing confidence among retail investors, but the recent uptick in public shareholding should be viewed with caution given the volatile earnings history. Overall, the stable promoter holding combined with a gradual increase in public participation could enhance governance and strategic decision-making going forward.
Outlook, Risks, and Final Insight
Looking ahead, HCP Plastene faces both opportunities and risks. The recovery in sales and profitability metrics suggests potential for growth, particularly if the company can stabilize its operational efficiencies and manage its costs effectively. However, the high leverage and cash conversion cycle present significant risks. Investors should be aware of the implications of rising interest rates on borrowing costs, which could pressure profitability. Additionally, fluctuations in quarterly earnings raise concerns about the consistency of operational performance. For retail investors, it may be prudent to adopt a cautious stance, focusing on the company’s ability to sustain its recovery while closely monitoring financial health and market conditions. Ultimately, HCP Plastene’s trajectory will depend on its capacity to navigate these challenges effectively, making it a stock worth watching in the evolving packaging sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HCP Plastene Bulkpack Ltd | 199 Cr. | 187 | 216/88.8 | 13.7 | 63.4 | 0.54 % | 13.2 % | 17.7 % | 10.0 |
| Time Technoplast Ltd | 9,168 Cr. | 186 | 254/153 | 21.8 | 67.1 | 0.67 % | 17.4 % | 14.2 % | 1.00 |
| Huhtamaki India Ltd | 1,545 Cr. | 206 | 295/170 | 15.6 | 163 | 0.97 % | 7.14 % | 5.15 % | 2.00 |
| Flexituff Ventures International Ltd | 48.5 Cr. | 15.4 | 74.3/12.4 | 7.08 | 0.00 % | 8.07 % | % | 10.0 | |
| Industry Average | 3,637.33 Cr | 148.60 | 17.03 | 75.15 | 0.55% | 11.45% | 12.35% | 5.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 111.04 | 93.80 | 69.46 | 77.22 | 59.37 | 78.87 | 79.68 | 76.63 | 104.70 | 117.08 | 119.37 | 122.28 | 125.75 |
| Expenses | 106.05 | 89.70 | 66.00 | 74.11 | 57.99 | 74.03 | 74.69 | 71.15 | 98.11 | 109.57 | 111.18 | 109.36 | 116.59 |
| Operating Profit | 4.99 | 4.10 | 3.46 | 3.11 | 1.38 | 4.84 | 4.99 | 5.48 | 6.59 | 7.51 | 8.19 | 12.92 | 9.16 |
| OPM % | 4.49% | 4.37% | 4.98% | 4.03% | 2.32% | 6.14% | 6.26% | 7.15% | 6.29% | 6.41% | 6.86% | 10.57% | 7.28% |
| Other Income | 1.86 | 0.10 | 0.02 | 0.32 | 0.25 | 0.89 | 0.20 | 1.22 | 1.30 | 0.57 | 0.93 | 1.88 | 6.51 |
| Interest | 1.90 | 2.06 | 2.32 | 3.10 | 2.50 | 2.72 | 3.07 | 3.45 | 3.33 | 3.43 | 3.97 | 3.89 | 4.16 |
| Depreciation | 1.77 | 1.82 | 1.95 | 1.84 | 1.80 | 1.89 | 1.81 | 1.80 | 1.71 | 1.70 | 2.06 | 1.82 | 1.82 |
| Profit before tax | 3.18 | 0.32 | -0.79 | -1.51 | -2.67 | 1.12 | 0.31 | 1.45 | 2.85 | 2.95 | 3.09 | 9.09 | 9.69 |
| Tax % | 33.02% | 56.25% | -32.91% | -37.09% | -19.85% | 14.29% | 6.45% | 16.55% | 26.32% | 26.44% | 28.80% | -15.95% | 26.42% |
| Net Profit | 2.13 | 0.12 | -0.55 | -0.95 | -2.14 | 0.96 | 0.28 | 1.21 | 2.10 | 2.18 | 2.20 | 10.54 | 7.13 |
| EPS in Rs | 0.37 | -1.00 | -0.23 | -1.22 | -1.41 | 0.21 | -0.42 | 0.52 | 1.36 | 1.41 | 1.41 | 4.72 | 3.76 |
Last Updated: August 19, 2025, 1:55 pm
Below is a detailed analysis of the quarterly data for HCP Plastene Bulkpack Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 125.75 Cr.. The value appears strong and on an upward trend. It has increased from 122.28 Cr. (Mar 2025) to 125.75 Cr., marking an increase of 3.47 Cr..
- For Expenses, as of Jun 2025, the value is 116.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.36 Cr. (Mar 2025) to 116.59 Cr., marking an increase of 7.23 Cr..
- For Operating Profit, as of Jun 2025, the value is 9.16 Cr.. The value appears to be declining and may need further review. It has decreased from 12.92 Cr. (Mar 2025) to 9.16 Cr., marking a decrease of 3.76 Cr..
- For OPM %, as of Jun 2025, the value is 7.28%. The value appears to be declining and may need further review. It has decreased from 10.57% (Mar 2025) to 7.28%, marking a decrease of 3.29%.
- For Other Income, as of Jun 2025, the value is 6.51 Cr.. The value appears strong and on an upward trend. It has increased from 1.88 Cr. (Mar 2025) to 6.51 Cr., marking an increase of 4.63 Cr..
- For Interest, as of Jun 2025, the value is 4.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.89 Cr. (Mar 2025) to 4.16 Cr., marking an increase of 0.27 Cr..
- For Depreciation, as of Jun 2025, the value is 1.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.82 Cr..
- For Profit before tax, as of Jun 2025, the value is 9.69 Cr.. The value appears strong and on an upward trend. It has increased from 9.09 Cr. (Mar 2025) to 9.69 Cr., marking an increase of 0.60 Cr..
- For Tax %, as of Jun 2025, the value is 26.42%. The value appears to be increasing, which may not be favorable. It has increased from -15.95% (Mar 2025) to 26.42%, marking an increase of 42.37%.
- For Net Profit, as of Jun 2025, the value is 7.13 Cr.. The value appears to be declining and may need further review. It has decreased from 10.54 Cr. (Mar 2025) to 7.13 Cr., marking a decrease of 3.41 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.76. The value appears to be declining and may need further review. It has decreased from 4.72 (Mar 2025) to 3.76, marking a decrease of 0.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:34 am
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 16 | 112 | 351 | 295 | 463 | 565 |
| Expenses | 19 | 106 | 334 | 278 | 428 | 524 |
| Operating Profit | -3 | 6 | 18 | 17 | 35 | 42 |
| OPM % | -20% | 5% | 5% | 6% | 8% | 7% |
| Other Income | 53 | 1 | 1 | 3 | 5 | 11 |
| Interest | 1 | 4 | 10 | 12 | 15 | 17 |
| Depreciation | 5 | 5 | 7 | 7 | 7 | 8 |
| Profit before tax | 44 | -3 | 1 | 0 | 18 | 29 |
| Tax % | -46% | -22% | 36% | -55% | 26% | |
| Net Profit | 64 | -2 | 1 | 0 | 13 | 25 |
| EPS in Rs | 38.79 | -2.86 | -2.07 | -1.11 | 9.02 | 13.60 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|
| YoY Net Profit Growth (%) | -103.12% | 150.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 253.12% | -250.00% |
HCP Plastene Bulkpack Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 3 years from 2021-2022 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 60% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 73% |
| TTM: | 577% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 110% |
| 3 Years: | -28% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 3:41 pm
Balance Sheet
Last Updated: December 4, 2025, 3:02 am
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 11 | 11 | 11 | 11 |
| Reserves | 16 | 15 | 39 | 39 | 49 | 57 |
| Borrowings | 38 | 109 | 123 | 158 | 190 | 201 |
| Other Liabilities | 8 | 39 | 27 | 25 | 35 | 54 |
| Total Liabilities | 72 | 174 | 200 | 233 | 285 | 322 |
| Fixed Assets | 27 | 79 | 84 | 77 | 73 | 70 |
| CWIP | 0 | 0 | 1 | 4 | 0 | 1 |
| Investments | 0 | 0 | 1 | 1 | 0 | 1 |
| Other Assets | 45 | 94 | 115 | 152 | 212 | 251 |
| Total Assets | 72 | 174 | 200 | 233 | 285 | 322 |
Below is a detailed analysis of the balance sheet data for HCP Plastene Bulkpack Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
- For Reserves, as of Sep 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2025) to 57.00 Cr., marking an increase of 8.00 Cr..
- For Borrowings, as of Sep 2025, the value is 201.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 190.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 11.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 54.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 19.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 322.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 285.00 Cr. (Mar 2025) to 322.00 Cr., marking an increase of 37.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 70.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2025) to 70.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 251.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2025) to 251.00 Cr., marking an increase of 39.00 Cr..
- For Total Assets, as of Sep 2025, the value is 322.00 Cr.. The value appears strong and on an upward trend. It has increased from 285.00 Cr. (Mar 2025) to 322.00 Cr., marking an increase of 37.00 Cr..
However, the Borrowings (201.00 Cr.) are higher than the Reserves (57.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -41.00 | -103.00 | -105.00 | -141.00 | -155.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 76 | 87 | 29 | 70 | 71 |
| Inventory Days | 225 | 115 | 38 | 65 | 61 |
| Days Payable | 245 | 94 | 10 | 7 | -1 |
| Cash Conversion Cycle | 56 | 108 | 57 | 129 | 133 |
| Working Capital Days | 85 | 43 | 28 | -5 | 7 |
| ROCE % | 1% | 6% | 6% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.57 | 0.37 | 1.06 | -2.39 | 65.80 |
| Diluted EPS (Rs.) | 12.50 | 0.37 | 1.01 | -2.39 | 65.80 |
| Cash EPS (Rs.) | 19.34 | 7.12 | 7.63 | 2.73 | 67.17 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 55.81 | 46.39 | 60.39 | 36.08 | 25.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 55.81 | 46.39 | 60.39 | 36.08 | 25.70 |
| Revenue From Operations / Share (Rs.) | 434.14 | 275.94 | 329.30 | 109.63 | 15.51 |
| PBDIT / Share (Rs.) | 37.39 | 18.01 | 16.65 | 5.84 | -3.42 |
| PBIT / Share (Rs.) | 30.56 | 11.18 | 9.73 | 0.72 | -8.43 |
| PBT / Share (Rs.) | 16.87 | 0.18 | 1.11 | -3.09 | 42.53 |
| Net Profit / Share (Rs.) | 12.51 | 0.28 | 0.71 | -2.39 | 62.17 |
| NP After MI And SOA / Share (Rs.) | 9.02 | -1.11 | -2.07 | -2.39 | 62.17 |
| PBDIT Margin (%) | 8.61 | 6.52 | 5.05 | 5.33 | -22.05 |
| PBIT Margin (%) | 7.03 | 4.04 | 2.95 | 0.65 | -54.33 |
| PBT Margin (%) | 3.88 | 0.06 | 0.33 | -2.81 | 274.26 |
| Net Profit Margin (%) | 2.88 | 0.10 | 0.21 | -2.18 | 400.86 |
| NP After MI And SOA Margin (%) | 2.07 | -0.40 | -0.62 | -2.18 | 400.86 |
| Return on Networth / Equity (%) | 16.15 | -2.39 | -4.41 | -9.54 | 241.85 |
| Return on Capital Employeed (%) | 28.33 | 10.45 | 6.92 | 0.59 | -13.40 |
| Return On Assets (%) | 3.37 | -0.50 | -1.10 | -1.41 | 87.93 |
| Long Term Debt / Equity (X) | 0.54 | 0.96 | 1.63 | 3.42 | 1.44 |
| Total Debt / Equity (X) | 3.19 | 3.19 | 2.44 | 4.24 | 1.44 |
| Asset Turnover Ratio (%) | 1.79 | 1.36 | 1.88 | 0.64 | 0.00 |
| Current Ratio (X) | 1.06 | 0.97 | 1.56 | 1.24 | 1.50 |
| Quick Ratio (X) | 0.72 | 0.67 | 1.02 | 0.72 | 0.68 |
| Inventory Turnover Ratio (X) | 10.08 | 9.35 | 6.67 | 5.49 | 0.00 |
| Interest Coverage Ratio (X) | 2.73 | 1.64 | 1.89 | 1.53 | -2.76 |
| Interest Coverage Ratio (Post Tax) (X) | 1.91 | 1.03 | 1.06 | 0.37 | 9.05 |
| Enterprise Value (Cr.) | 319.31 | 372.53 | 338.47 | 713.16 | 47.08 |
| EV / Net Operating Revenue (X) | 0.68 | 1.26 | 0.96 | 6.36 | 2.97 |
| EV / EBITDA (X) | 8.00 | 19.38 | 19.05 | 119.23 | -13.45 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.67 | 0.57 | 5.29 | 0.58 |
| Price / BV (X) | 1.85 | 4.03 | 4.05 | 23.13 | 0.35 |
| Price / Net Operating Revenue (X) | 0.23 | 0.67 | 0.57 | 5.29 | 0.58 |
| EarningsYield | 0.08 | -0.01 | -0.01 | 0.00 | 6.83 |
After reviewing the key financial ratios for HCP Plastene Bulkpack Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.57. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 12.57, marking an increase of 12.20.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 12.50, marking an increase of 12.13.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.34. This value is within the healthy range. It has increased from 7.12 (Mar 24) to 19.34, marking an increase of 12.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has increased from 46.39 (Mar 24) to 55.81, marking an increase of 9.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has increased from 46.39 (Mar 24) to 55.81, marking an increase of 9.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 434.14. It has increased from 275.94 (Mar 24) to 434.14, marking an increase of 158.20.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 37.39. This value is within the healthy range. It has increased from 18.01 (Mar 24) to 37.39, marking an increase of 19.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.56. This value is within the healthy range. It has increased from 11.18 (Mar 24) to 30.56, marking an increase of 19.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.87. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 16.87, marking an increase of 16.69.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 12.51, marking an increase of 12.23.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has increased from -1.11 (Mar 24) to 9.02, marking an increase of 10.13.
- For PBDIT Margin (%), as of Mar 25, the value is 8.61. This value is below the healthy minimum of 10. It has increased from 6.52 (Mar 24) to 8.61, marking an increase of 2.09.
- For PBIT Margin (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 10. It has increased from 4.04 (Mar 24) to 7.03, marking an increase of 2.99.
- For PBT Margin (%), as of Mar 25, the value is 3.88. This value is below the healthy minimum of 10. It has increased from 0.06 (Mar 24) to 3.88, marking an increase of 3.82.
- For Net Profit Margin (%), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 5. It has increased from 0.10 (Mar 24) to 2.88, marking an increase of 2.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 8. It has increased from -0.40 (Mar 24) to 2.07, marking an increase of 2.47.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.15. This value is within the healthy range. It has increased from -2.39 (Mar 24) to 16.15, marking an increase of 18.54.
- For Return on Capital Employeed (%), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from 10.45 (Mar 24) to 28.33, marking an increase of 17.88.
- For Return On Assets (%), as of Mar 25, the value is 3.37. This value is below the healthy minimum of 5. It has increased from -0.50 (Mar 24) to 3.37, marking an increase of 3.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.54, marking a decrease of 0.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 24) which recorded 3.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.79. It has increased from 1.36 (Mar 24) to 1.79, marking an increase of 0.43.
- For Current Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 1.5. It has increased from 0.97 (Mar 24) to 1.06, marking an increase of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.72, marking an increase of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.08. This value exceeds the healthy maximum of 8. It has increased from 9.35 (Mar 24) to 10.08, marking an increase of 0.73.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 3. It has increased from 1.64 (Mar 24) to 2.73, marking an increase of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 3. It has increased from 1.03 (Mar 24) to 1.91, marking an increase of 0.88.
- For Enterprise Value (Cr.), as of Mar 25, the value is 319.31. It has decreased from 372.53 (Mar 24) to 319.31, marking a decrease of 53.22.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has decreased from 1.26 (Mar 24) to 0.68, marking a decrease of 0.58.
- For EV / EBITDA (X), as of Mar 25, the value is 8.00. This value is within the healthy range. It has decreased from 19.38 (Mar 24) to 8.00, marking a decrease of 11.38.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
- For Price / BV (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 1.85, marking a decrease of 2.18.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.08, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in HCP Plastene Bulkpack Ltd:
- Net Profit Margin: 2.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.33% (Industry Average ROCE: 11.45%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.15% (Industry Average ROE: 9.26%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.7 (Industry average Stock P/E: 12.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | H B Jirawala House, Ahmedabad Gujarat 380013 | cs@gopalapolyplast.com http://www.gopalapolyplast.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Shyamsunder Goyal | Chairman |
| Mr. Prakash Hiralal Parekh | Managing Director |
| Mr. Sandeep Motilal Shah | Ind. Non-Executive Director |
| Ms. Meenu Maheshwari | Ind. Non-Executive Director |
| Dr. Ranjeet Mal kastia | Ind. Non-Executive Director |
| Mr. Aman Prakash Parekh | Executive Director |
FAQ
What is the intrinsic value of HCP Plastene Bulkpack Ltd?
HCP Plastene Bulkpack Ltd's intrinsic value (as of 18 December 2025) is 123.66 which is 33.87% lower the current market price of 187.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 199 Cr. market cap, FY2025-2026 high/low of 216/88.8, reserves of ₹57 Cr, and liabilities of 322 Cr.
What is the Market Cap of HCP Plastene Bulkpack Ltd?
The Market Cap of HCP Plastene Bulkpack Ltd is 199 Cr..
What is the current Stock Price of HCP Plastene Bulkpack Ltd as on 18 December 2025?
The current stock price of HCP Plastene Bulkpack Ltd as on 18 December 2025 is 187.
What is the High / Low of HCP Plastene Bulkpack Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of HCP Plastene Bulkpack Ltd stocks is 216/88.8.
What is the Stock P/E of HCP Plastene Bulkpack Ltd?
The Stock P/E of HCP Plastene Bulkpack Ltd is 13.7.
What is the Book Value of HCP Plastene Bulkpack Ltd?
The Book Value of HCP Plastene Bulkpack Ltd is 63.4.
What is the Dividend Yield of HCP Plastene Bulkpack Ltd?
The Dividend Yield of HCP Plastene Bulkpack Ltd is 0.54 %.
What is the ROCE of HCP Plastene Bulkpack Ltd?
The ROCE of HCP Plastene Bulkpack Ltd is 13.2 %.
What is the ROE of HCP Plastene Bulkpack Ltd?
The ROE of HCP Plastene Bulkpack Ltd is 17.7 %.
What is the Face Value of HCP Plastene Bulkpack Ltd?
The Face Value of HCP Plastene Bulkpack Ltd is 10.0.